![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 19, 2014 12:51:24 AM
BioHeart then went on to tweet
Bioheart’s Scientific Advisory Board is composed of scientists, M.D.'s and Ph.D.s. See more: bit.ly/1nB8sUG
So I checked it out and saw listed:
George J. Magovern, M.D. Cardiac surgery Retired Chairman Department of Cardiothoracic Surgery Allegheny Hospital Pittsburgh, Pennsylvania
Note Pennsylvania.
So then I checked where the temple university school of medicine was and it turned out to be in Pennsylvania.
My question to you is, do you believe George J. Magovern M.D. Is Jon George, MD, just with his name disguised a bit since the information was intently kept under wraps as far as what companies phase 3 trials they were talking about?
Or am I looking to hard between the lines?? If I'm accurate, that means that continued phase 3 enrollment news is around the corner IMO.
FEATURED Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • Sep 10, 2024 11:00 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM